Recruiting NA Stroke

New treatment option for Stroke

Official title Improving Sleep and Learning in Rehabilitation After Stroke, Part 2

ClinicalTrials.gov ID: NCT05511285

What this study is testing

What it's testing
This study will explore whether sleep in stroke survivors is improved with digital cognitive behavioural therapy for insomnia (Sleepio), in comparison to treatment as usual, and will explore whether changes in sleep relate to changes in overnight consolidation of motor learning.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Willing and able to give informed consent for participation in the study
  • Aged 18 years or above.
  • Clinical diagnosis of stroke affecting the upper limb, with sufficient movement to perform the motor learning task
  • Discharged from inpatient care
  • Interest in accessing a programme with the aim of improving sleep quality

You likely can't join if

  • Other neurological condition affecting movement (e.g. Parkinson's Disease, Multiple Sclerosis)
  • Diagnosed, untreated, sleep disorder (e.g. Sleep Apnea)
  • Uncontrolled seizures
  • Planned inpatient admission (e.g. for rehabilitation) in the next 4 months that would impact ability to engage with the Sleepio programme
  • Engagement in psychological therapy for insomnia in the past 12 months
  • Pregnancy
See the full eligibility criteria
Who can join
  • Willing and able to give informed consent for participation in the study
  • Aged 18 years or above.
  • Clinical diagnosis of stroke affecting the upper limb, with sufficient movement to perform the motor learning task
  • Discharged from inpatient care
  • Interest in accessing a programme with the aim of improving sleep quality
  • Reliable access to the internet
What rules you out
  • Other neurological condition affecting movement (e.g. Parkinson's Disease, Multiple Sclerosis)
  • Diagnosed, untreated, sleep disorder (e.g. Sleep Apnea)
  • Uncontrolled seizures
  • Planned inpatient admission (e.g. for rehabilitation) in the next 4 months that would impact ability to engage with the Sleepio programme
  • Engagement in psychological therapy for insomnia in the past 12 months
  • Pregnancy

The study team makes the final eligibility decision.

Where it's taking place

  • Oxford, United Kingdom

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Oxford, United Kingdom. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.